Source comparison
PT-141 vs Melanotan II: Structural Similarity, Different Indications
PT-141 is a synthetic analog of Melanotan II, a peptide originally developed for tanning and later studied for erectile function. Both compounds activate melanocortin receptors, but PT-141 was specifically modified to reduce affinity for MC1R (the receptor res
This comparison does not assign a generated winner or score.
- PT-141 is a synthetic analog of Melanotan II, a peptide originally developed for tanning and later studied for erectile function. Both compounds activate melanocortin receptors, but PT-141 was specifically modified to reduce affinity for MC1R (the receptor responsible for skin pigmentation) while maintaining potent MC4R activation. This structural refinement eliminated the tanning side effect while preserving the central sexual arousal mechanism. Which is why bremelanotide (PT-141) progressed to FDA approval while Melanotan II remains an unapproved research compound.
- The key difference is selectivity. Melanotan II is a non-selective melanocortin agonist. It activates MC1R (tanning), MC3R and MC4R (sexual arousal), and MC5R (exocrine gland function). PT-141's chemical modification shifted receptor binding away from MC1R, making it a more targeted therapeutic candidate. Clinical trials showed bremelanotide produced minimal to no skin darkening at therapeutic doses, whereas Melanotan II users consistently reported tanning as a primary effect.
- From a research perspective, the compounds serve different purposes. Melanotan II is studied for its broader melanocortin effects. Appetite suppression, tanning, potential neuroprotective properties. While PT-141 is a single-indication peptide designed for HSDD. Research-grade suppliers like Real Peptides provide both compounds for investigational use, but the intended study designs differ significantly. Melanotan II studies often explore metabolic or dermatological endpoints; PT-141 studies focus on neurobehavioral measures of sexual desire and arousal.